Horizon Pharma

Horizon has reworked its forecast.

Horizon reworks financial forecast; investors not happy

There is more uncertainty on the horizon for investors in Horizon. Last month, it was the disclosure of a Department of Justice (DOJ) probe into pricing. Today, Horizon Pharma disclosed that it will be the second half of the year before the company will realize about 60% of its net sales and earnings.